| Home > Publications Database > MRI end-points for clinical trials in ataxias: recommendations from the Ataxia Global Initiative MRI Biomarkers Working Group. > Access to Fulltext |
| Restricted | |||||||
DZNE-2026-00694 SUP
|
|||||||
| version 1 |
| ||||||
| Restricted | |||||||
DZNE-2026-00694_Restricted
|
|||||||
| version 1 |
| ||||||